China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China flag China · Delayed Price · Currency is CNY
17.88
+0.06 (0.34%)
Apr 28, 2026, 3:00 PM CST

SHA:600062 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
10,60910,88111,11911,1779,5229,034
Other Revenue
119.54119.5492.76133.12102.9977.88
10,72911,00111,21211,3109,6259,112
Revenue Growth (YoY)
-3.74%-1.88%-0.87%17.50%5.64%7.14%
Cost of Revenue
4,5944,6604,8324,9044,3074,048
Gross Profit
6,1346,3416,3806,4065,3185,064
Selling, General & Admin
3,8774,0064,1273,9373,4783,502
Research & Development
526.66531.6555.19627.85482.48409.59
Other Operating Expenses
76.1688.5775.98106.24119.35115.75
Operating Expenses
4,4894,6354,7394,6814,0814,029
Operating Income
1,6461,7061,6411,7251,2371,034
Interest Expense
-33.58-33.58-15.36-15.4-10.62-11.62
Interest & Investment Income
164.93164.93198.56190.5689.6881.55
Earnings From Equity Investments
33.28---16.23-
Currency Exchange Gain (Loss)
-3.53-3.539.196.618.06-4.97
Other Non Operating Income (Expenses)
-26.181.2529.9361.36.360.26
EBT Excluding Unusual Items
1,7811,8361,8631,9681,3571,099
Impairment of Goodwill
---29.41-28.9--56.68
Gain (Loss) on Sale of Investments
3.291.83-1.6413.75.9935.36
Gain (Loss) on Sale of Assets
-8.55-10.146.840.18-2.271.03
Asset Writedown
-25.96-22.76-59.17-57.52-8.43-0.54
Other Unusual Items
106.25106.2546.6140.8582.7642.65
Pretax Income
1,8561,9111,8671,9371,4351,121
Income Tax Expense
193.68227.52215.94272.71201.27149.06
Earnings From Continuing Operations
1,6621,6831,6511,6641,234972.13
Minority Interest in Earnings
-36.72-36.27-23.026.29-53.59-36.45
Net Income
1,6251,6471,6281,6701,180935.69
Net Income to Common
1,6251,6471,6281,6701,180935.69
Net Income Growth
0.24%1.18%-2.55%41.55%26.12%-6.91%
Shares Outstanding (Basic)
1,0341,0331,0281,0241,0361,043
Shares Outstanding (Diluted)
1,0361,0341,0281,0241,0361,043
Shares Change (YoY)
0.68%0.61%0.33%-1.07%-0.74%-
EPS (Basic)
1.571.591.581.631.140.90
EPS (Diluted)
1.571.591.581.631.140.90
EPS Growth
-0.43%0.57%-2.87%43.09%27.06%-6.91%
Free Cash Flow
741.45869.881,1881,245889.57849.25
Free Cash Flow Per Share
0.720.841.161.220.860.81
Dividend Per Share
0.4790.4790.4710.2570.5780.480
Dividend Growth
1.70%1.70%83.27%-55.54%20.42%65.52%
Gross Margin
57.18%57.64%56.91%56.64%55.25%55.57%
Operating Margin
15.34%15.51%14.64%15.26%12.85%11.35%
Profit Margin
15.15%14.97%14.52%14.77%12.26%10.27%
Free Cash Flow Margin
6.91%7.91%10.59%11.01%9.24%9.32%
EBITDA
2,4062,4602,3702,3901,7781,482
EBITDA Margin
22.42%22.36%21.14%21.13%18.47%16.26%
D&A For EBITDA
760.03753.81728.93664.52540.36447.4
EBIT
1,6461,7061,6411,7251,2371,034
EBIT Margin
15.34%15.51%14.64%15.26%12.85%11.35%
Effective Tax Rate
10.44%11.91%11.57%14.08%14.03%13.30%
Revenue as Reported
11,00111,00111,21211,3109,6259,112
Advertising Expenses
-79.3985.9635.82--
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.